Rani Therapeutics
RANI
RANI
35 hedge funds and large institutions have $13.3M invested in Rani Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $15.5M → $13.3M (-$2.22M)
75% less call options, than puts
Call options by funds: $13K | Put options by funds: $51K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
35
Holding in Top 10
–
Calls
$13K
Puts
$51K
Top Buyers
| 1 | +$654K | |
| 2 | +$243K | |
| 3 | +$231K | |
| 4 |
Renaissance Technologies
New York
|
+$194K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$170K |
Top Sellers
| 1 | -$365K | |
| 2 | -$173K | |
| 3 | -$103K | |
| 4 |
IWP
Icon Wealth Partners
Houston,
Texas
|
-$65.8K |
| 5 |
CL
Choreo LLC
Rockford,
Illinois
|
-$20.6K |